{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:28Z","timestamp":1791919528901,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DAO33211"],"award-info":[{"award-number":["R25DAO33211"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11606-021-07035-6","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T21:02:51Z","timestamp":1649797371000},"page":"2103-2109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Benzodiazepine-Involved Overdose Deaths in the USA: 2000\u20132019"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-0073","authenticated-orcid":false,"given":"Robert A","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"7035_CR1","doi-asserted-by":"publisher","unstructured":"Gladden RM. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine \u2014 25 states, July\u2013December 2017 to January\u2013June 2018. MMWR Morb Mortal Wkly Rep. 2019;68. https:\/\/doi.org\/10.15585\/mmwr.mm6834a2","DOI":"10.15585\/mmwr.mm6834a2"},{"issue":"4","key":"7035_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2361","volume":"3","author":"ME Tori","year":"2020","unstructured":"Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017. JAMA Netw Open. 2020;3(4):e202361. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2361","journal-title":"JAMA Netw Open."},{"key":"7035_CR3","unstructured":"National Institute on Drug Abuse. Overdose death rates. Published January 29, 2021. Accessed March 20, 2021. https:\/\/www.drugabuse.gov\/drug-topics\/trends-statistics\/overdose-death-rates"},{"issue":"8","key":"7035_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","volume":"378","author":"A Lembke","year":"2018","unstructured":"Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med. 2018;378(8):693-695. https:\/\/doi.org\/10.1056\/NEJMp1715050","journal-title":"N Engl J Med."},{"key":"7035_CR5","unstructured":"Centers for Disease Control and Prevention. Mortality multiple cause files. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2018. https:\/\/www.cdc.gov\/nchs\/data_access\/vitalstatsonline.htm"},{"key":"7035_CR6","unstructured":"National Center for Health Statistics. About the National Vital Statistics System. Published January 4, 2016. Accessed May 29, 2021. https:\/\/www.cdc.gov\/nchs\/nvss\/about_nvss.htm"},{"issue":"13","key":"7035_CR7","first-page":"83","volume":"69","author":"S Murphy","year":"2021","unstructured":"Murphy S, Xu J, Kochanek K, Arias E, Tejada-Vera B. Deaths: final data for 2018. National Vital Statistics Reports. 2021;69(13):83.","journal-title":"National Vital Statistics Reports."},{"key":"7035_CR8","unstructured":"National Center for Health Statistics. U.S. Census populations with bridged race categories. Published July 6, 2020. Accessed May 27, 2021. https:\/\/www.cdc.gov\/nchs\/nvss\/bridged_race.htm"},{"issue":"8","key":"7035_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med."},{"issue":"7","key":"7035_CR10","first-page":"2121","volume":"61","author":"LP Longo","year":"2000","unstructured":"Longo LP, Johnson B. Addiction: Part I. Benzodiazepines-side effects, abuse risk and alternatives. AFP. 2000;61(7):2121.","journal-title":"AFP."},{"key":"7035_CR11","unstructured":"Centers for Disease Control and Prevention. CDC WONDER. Published December 22, 2020. Accessed June 22, 2021. https:\/\/wonder.cdc.gov\/"},{"key":"7035_CR12","doi-asserted-by":"publisher","unstructured":"Jones CM. Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths \u2014 United States, 2002\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65. https:\/\/doi.org\/10.15585\/mmwr.mm6526a2","DOI":"10.15585\/mmwr.mm6526a2"},{"issue":"15","key":"7035_CR13","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645. https:\/\/doi.org\/10.1001\/jama.2016.1464","journal-title":"JAMA."},{"issue":"6","key":"7035_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","volume":"169","author":"ASB Bohnert","year":"2018","unstructured":"Bohnert ASB, Guy GP, Losby JL. Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline. Ann Intern Med. 2018;169(6):367-375. https:\/\/doi.org\/10.7326\/M18-1243","journal-title":"Ann Intern Med."},{"issue":"17","key":"7035_CR15","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1001\/jama.2018.2844","volume":"319","author":"CM Jones","year":"2018","unstructured":"Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA. 2018;319(17):1819-1821. https:\/\/doi.org\/10.1001\/jama.2018.2844","journal-title":"JAMA."},{"key":"7035_CR16","unstructured":"Centers for Disease Control and Prevention. Understanding the epidemic | drug overdose | CDC Injury Center. Published March 17, 2021. Accessed May 30, 2021. https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html"},{"issue":"4","key":"7035_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry. 2021;34(4):344-350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717","journal-title":"Current Opinion in Psychiatry."},{"issue":"2","key":"7035_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1073110518782949","volume":"46","author":"K James","year":"2018","unstructured":"James K, Jordan A. The opioid crisis in Black communities. J Law Med Ethics. 2018;46(2):404-421. https:\/\/doi.org\/10.1177\/1073110518782949","journal-title":"J Law Med Ethics."},{"key":"7035_CR19","doi-asserted-by":"publisher","first-page":"107612","DOI":"10.1016\/j.drugalcdep.2019.107612","volume":"205","author":"HS Connery","year":"2019","unstructured":"Connery HS, Taghian N, Kim J, et al. Suicidal motivations reported by opioid overdose survivors: a cross-sectional study of adults with opioid use disorder. Drug and Alcohol Dependence. 2019;205:107612. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107612","journal-title":"Drug and Alcohol Dependence."},{"key":"7035_CR20","unstructured":"Arias E, Heron M, National Center for Health Statistics, Hakes J, US Census Bureau. The validity of race and Hispanic-origin reporting on death certificates in the United States: an update. Vital Health Stat 2. 2016;(172):1-21."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-07035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-07035-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-07035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:03:43Z","timestamp":1681257823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-07035-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7035"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-07035-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Weiss has served as a consultant to Astellas Pharmaceuticals, Cerevel Therapeutics, Analgesic Solutions, Takeda Pharmaceuticals, and Janssen Pharmaceuticals. Dr. Kleinman has received funding from the Centre for Addiction and Mental Health Discovery Fund and the Research in Addiction Medicine Scholars Program\u00a0(National Institute on Drug Abuse R25DAO33211) and travel awards from the American Psychiatric Association and the American Academy on Addiction Psychiatry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}